Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
784 studies found for:    "Calcium heparin"
Show Display Options
Rank Status Study
1 Recruiting A Comparison of Dilute Versus Concentrated Heparin for CRRT Anticoagulation
Conditions: Acute Kidney Injury;   Acute Renal Failure;   Heart Failure
Interventions: Drug: Dilute unfractionated heparin;   Drug: Standard concentration unfractionated heparin
2 Unknown  DEDICA (Dose of HEparin During Coronary Angioplasty) Trial
Conditions: Stable Angina;   Angina, Unstable;   Non-ST Elevation (NSTEMI) Myocardial Infarction
Interventions: Drug: Low-dose heparin;   Drug: Standard dose heparin
3 Recruiting Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin
Conditions: Aneurysmal Subarachnoid Hemorrhage;   Neurobehavioral Manifestations;   Vasospasm, Intracranial;   Intracranial Aneurysm;   Heparin-induced Thrombocytopenia Type II
Intervention: Drug: Continuous Low-Dose Intravenous Unfractionated Heparin Infusion (14 days)
4 Recruiting Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure
Condition: Aortic Stenosis, Non-rheumatic
Interventions: Drug: Heparin;   Drug: NaCl
5 Completed Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation
Condition: Coagulation; Intravascular
Interventions: Drug: Continuous heparin infusion;   Drug: Intermittent heparin infusion
6 Completed Optimized Heparin Regimen in Vascular Surgery
Condition: Peripheral Revascularisation
Interventions: Procedure: ACT;   Procedure: TEG;   Procedure: Ankle-brachial index;   Procedure: Toe-brachial index;   Drug: Heparin
7 Withdrawn Safety of Heparin in Patients With Septic Shock
Condition: Sepsis
Intervention: Drug: heparin
8 Completed HEROIC (Heparin Requirement in Counterpulsation)
Condition: Cardiogenic Shock
Interventions: Drug: Heparin;   Other: Without Heparin
9 Completed Comparative Study of Two Brands of Heparin Already on the Market
Condition: Coronary Artery Bypass Grafting
Intervention: Drug: Heparin Leo and Hepalean
10 Not yet recruiting Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation
Conditions: Sepsis;   Disseminated Intravascular Coagulation
Interventions: Drug: Heparin Sodium;   Drug: Saline
11 Completed Multi-center Study to Investigate the Effects of Citrasate® on Heparin N Requirements During Hemodialysis Treatment
Condition: Renal Dialysis
Intervention: Drug: Heparin N reduction
12 Recruiting High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion
Condition: Coronary Angiography
Interventions: Drug: High dose of Unfractionated Heparin;   Drug: Standard dose of Unfractionated heparin
13 Completed Pregnancy Outcomes in Women With Recurrent Miscarriage Treated With Low Dose Aspirin and Unfractionated Heparin
Condition: Recurrent Miscarriage
Intervention: Drug: Heparin
14 Unknown  Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.
Condition: To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out Come
Interventions: Drug: Low molecular weight heparin;   Drug: Low dose aspirin;   Drug: Heparin & aspirin;   Other: NaCl
15 Completed Clinical Trial Comparing Heparin and Protamine Fixed and Titrated Doses in Cardiac Surgery With Cardiopulmonary Bypass
Conditions: Cardiac Surgery;   Cardiopulmonary Bypass;   Anticoagulation
Interventions: Drug: Heparin fixed doses;   Drug: PO continuous infusion of Protamine;   Drug: Heparin and protamine titration
16 Completed Optimal Heparin Dosing Regimens for Cardiopulmonary Bypass
Condition: Postoperative Hemorrhage
Interventions: Drug: Heparin;   Drug: HH or high heparin;   Drug: heparin concentration HC
17 Completed A Comparison of Certoparin and Unfractionated Heparin in the Prevention of Thromboembolic Events in Acutely Ill Medical Patients
Condition: Thromboembolism
Interventions: Drug: Certoparin;   Drug: Unfractionated Heparin
18 Active, not recruiting The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI
Condition: LOVASTATIN/TICAGRELOR [VA Drug Interaction]
Interventions: Drug: Ticagrelor;   Drug: full amount low molecular weight heparin;   Drug: half amount low molecular weight heparin;   Drug: No low molecular weight heparin
19 Completed Low Molecular Weight Heparin for Hemodialysis Anticoagulation
Condition: End Stage Renal Failure on Dialysis
Interventions: Drug: low molecular weight heparin (enoxaparin sodium);   Drug: standard unfractionated heparin
20 Active, not recruiting Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART
Conditions: ST-segment Elevation Myocardial Infarction;   Non ST-segment Elevation Myocardial Infarction
Interventions: Drug: bivalirudin;   Drug: Heparin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years